Suppression of experimental allergic encephalomyelitis by NSC 82196, a new imidazole carboxamide derivative.
D000577:Amides / Q000627:therapeutic use; D000818:Animals; D001379:Azathioprine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004195:Disease Models, Animal / Q000188:drug therapy; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy*; D005260:Female; D007093:Imidazoles / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008727:Methotrexate / Q000627:therapeutic use; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D051381:Rats
D000577:Amides; D007093:Imidazoles; D007166:Immunosuppressive Agents; D009588:Nitrogen Mustard Compounds; D003520:Cyclophosphamide; D001379:Azathioprine; D008727:Methotrexate